Dr. Mahler is Founder, CEO and Board Member at ten23 health AG, the human-centric and sustainable pharmaceutical development partner.
Previously, Dr. Mahler has been leading the Drug Product Services Business Unit at Lonza AG, leading Pharmaceutical Development & Supplies Biologics at Roche (Basel), and as Principal Scientist & CMC Team leader Erbitux at Merck KGaA.
He is also adjunct faculty at the Universities of Frankfurt (Germany) and Basel (Switzerland), serves as Scientifc Expert (Ph.Eur.) at EDQM and as Board Member for Bionter & KriyaBio.
He studied Pharmacy & holds in Ph.D. in Toxicology from the University of Mainz.
Presentation Title: